Value of cardiopulmonary exercise testing in the diagnosis of coronary artery disease

Berna Akıncı Özyürek1, Şerife Savaş Bozbaş2, Alp Aydınalp3

  • 1Clinic of Chest Diseases, Ankara Ataturk Chest Diseases and Thoracic Surgery Education and Research Hospital, Ankara, Turkey.

Tuberkuloz Ve Toraks
|August 16, 2019
PubMed

Insights

Cardiopulmonary exercise testing (CPET) parameters like VE/VCO2 at anaerobic threshold and heart rate reserve may predict coronary artery disease (CAD). These CPET findings can aid in diagnosing CAD in patients with angina and dyspnea.

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Cardiopulmonary exercise testing (CPET) offers comprehensive hemodynamic data during exercise, surpassing traditional treadmill tests.
  • Evaluating respiratory and cardiac functions alongside skeletal and neurophysiologic systems is crucial for patient assessment.

Purpose of the Study:

  • To investigate the correlation between CPET findings and coronary artery lesions identified via coronary angiography (CAG).
  • To identify predictive CPET parameters for coronary artery disease (CAD) in patients experiencing angina pectoris.

Main Methods:

  • Thirty patients with suspected CAD underwent treadmill exercise, CPET, and CAG.
  • Key CPET parameters including oxygen consumption (VO2), minute ventilation (VE), and heart rate reserve (HRR) were analyzed.
  • Significant CAD was defined as ≥50% narrowing in coronary arteries.

Main Results:

  • CAD was detected in 59.4% of the study participants.
  • Significant differences were observed in HRR, VE/VCO2 at anaerobic threshold (AT), and VO2 at AT between patients with and without CAD (p<0.05).
  • While peak VO2 and O2 pulse were higher in patients without CAD, this difference was not statistically significant.

Conclusions:

  • CPET parameters such as VE/VCO2 at AT, VO2 at AT, and HRR show potential predictive value for diagnosing CAD.
  • These parameters may assist in evaluating patients with angina and dyspnea who are suspected of having CAD.
  • CPET-derived metrics unaffected by patient effort can enhance its diagnostic utility for CAD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
903
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
380
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
218
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
596
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
324